REACtiVe-2: phase I evaluation of dendritic cell vaccination and agonistic CD40 therapy following (m)FOLFIRINOX in metastatic pancreatic cancer

Songul Kucukcelebi, Freek R. van ‘t Land, Sjoerd H. van der Burg, Ferry A. L. M. Eskens, Marjolein Y. V. Homs, Marcella Willemsen, Anne Onrust-van Schoonhoven, Nina E. M. Rozendaal, Amine Fellah, Disha Vadgama, Miranda Moskie, Koen Bezemer, Michail Doukas, Casper W. F. van Eijck, Ralph Stadhouders, Judith de Vos-Geelen, Aniek E. van Diepen, Ilona Enninga, Rob Meijer, Sumeet V. Ambarkhane, Peter Ellmark, Joachim G. J. V. Aerts, Christianne Groeneveldt, Casper H. J. van Eijck

Open source

DOI: 10.1038/s41467-025-66092-1
Published: 2025-11-28
Container: Nature Communications
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41467-025-66092-1,
  title = {REACtiVe-2: phase I evaluation of dendritic cell vaccination and agonistic CD40 therapy following (m)FOLFIRINOX in metastatic pancreatic cancer},
  author = {Songul Kucukcelebi and Freek R. van ‘t Land and Sjoerd H. van der Burg and Ferry A. L. M. Eskens and Marjolein Y. V. Homs and Marcella Willemsen and Anne Onrust-van Schoonhoven and Nina E. M. Rozendaal and Amine Fellah and Disha Vadgama and Miranda Moskie and Koen Bezemer and Michail Doukas and Casper W. F. van Eijck and Ralph Stadhouders and Judith de Vos-Geelen and Aniek E. van Diepen and Ilona Enninga and Rob Meijer and Sumeet V. Ambarkhane and Peter Ellmark and Joachim G. J. V. Aerts and Christianne Groeneveldt and Casper H. J. van Eijck},
  year = {2025},
  journal = {Nature Communications},
  doi = {10.1038/s41467-025-66092-1},
  url = {https://doi.org/10.1038/s41467-025-66092-1}
}

RIS

TY  - JOUR
TI  - REACtiVe-2: phase I evaluation of dendritic cell vaccination and agonistic CD40 therapy following (m)FOLFIRINOX in metastatic pancreatic cancer
AU  - Songul Kucukcelebi
AU  - Freek R. van ‘t Land
AU  - Sjoerd H. van der Burg
AU  - Ferry A. L. M. Eskens
AU  - Marjolein Y. V. Homs
AU  - Marcella Willemsen
AU  - Anne Onrust-van Schoonhoven
AU  - Nina E. M. Rozendaal
AU  - Amine Fellah
AU  - Disha Vadgama
AU  - Miranda Moskie
AU  - Koen Bezemer
AU  - Michail Doukas
AU  - Casper W. F. van Eijck
AU  - Ralph Stadhouders
AU  - Judith de Vos-Geelen
AU  - Aniek E. van Diepen
AU  - Ilona Enninga
AU  - Rob Meijer
AU  - Sumeet V. Ambarkhane
AU  - Peter Ellmark
AU  - Joachim G. J. V. Aerts
AU  - Christianne Groeneveldt
AU  - Casper H. J. van Eijck
PY  - 2025
JO  - Nature Communications
DO  - 10.1038/s41467-025-66092-1
UR  - https://doi.org/10.1038/s41467-025-66092-1
ER  -

APA

Kucukcelebi, S., Land, F. R. V. ‘., Burg, S. H. V. D., Eskens, F. A. L. M., Homs, M. Y. V., Willemsen, M., Schoonhoven, A. O., Rozendaal, N. E. M., Fellah, A., Vadgama, D., Moskie, M., Bezemer, K., Doukas, M., Eijck, C. W. F. V., Stadhouders, R., Vos-Geelen, J. D., Diepen, A. E. V., Enninga, I., Meijer, R., Ambarkhane, S. V., Ellmark, P., Aerts, J. G. J. V., Groeneveldt, C., & Eijck, C. H. J. V. (2025). REACtiVe-2: phase I evaluation of dendritic cell vaccination and agonistic CD40 therapy following (m)FOLFIRINOX in metastatic pancreatic cancer. Nature Communications. https://doi.org/10.1038/s41467-025-66092-1

Source records

crossref · retrieved 2026-09-27T08:15:31.980Z